Advertisement

Topics

AZ and MSD secure three bits of good news on key drug

04:51 EDT 18 Aug 2017 | Pharmafile

It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly formed Lynparza partnership with an expanded indication and new formulation approval.

In full, the news on the drug included:

read more

Original Article: AZ and MSD secure three bits of good news on key drug

NEXT ARTICLE

More From BioPortfolio on "AZ and MSD secure three bits of good news on key drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...